Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | BGB-B3227 |
Synonyms | |
Therapy Description |
Limited information is currently available on BGB-B3227, a putative bispecific antibody targeting MUC1 and CD16a (Sep 2024). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
BGB-B3227 | BGBB3227|BGB B3227 | Limited information is currently available on BGB-B3227, a putative bispecific antibody targeting MUC1 and CD16a (Sep 2024). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|